Murphy & Mullick Capital Management Corp Makes New $975,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Murphy & Mullick Capital Management Corp bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,868 shares of the medical equipment provider's stock, valued at approximately $975,000. Intuitive Surgical comprises 0.9% of Murphy & Mullick Capital Management Corp's investment portfolio, making the stock its 25th largest position.

Other institutional investors also recently modified their holdings of the company. Bennett Selby Investments LP boosted its holdings in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC boosted its stake in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC increased its position in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. lifted its holdings in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC boosted its stake in Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Analyst Ratings Changes

Several analysts recently commented on ISRG shares. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Bernstein Bank lifted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. Finally, CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $611.86.

Intuitive Surgical Stock Down 3.2 %

Shares of ISRG traded down $16.06 during midday trading on Friday, hitting $491.84. The company's stock had a trading volume of 1,966,546 shares, compared to its average volume of 1,527,047. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market capitalization of $175.18 billion, a price-to-earnings ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company's fifty day simple moving average is $556.28 and its two-hundred day simple moving average is $532.68.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.